Background

Apotea, Sweden's largest online pharmacy, recently listed on the Stockholm Stock Exchange with an initial subscription price of 58 SEK per share, valuing the company at approximately 6 billion SEK. The company has established itself as a major player in the Swedish e-pharmacy market.

Resolution Criteria

This market will resolve as YES if Apotea's stock price (APOTEA) reaches or exceeds 200 SEK at any point during calendar year 2025 (January 1, 2025 00:00 CET to December 31, 2025 23:59 CET) according to the Stockholm Stock Exchange's official trading data. The price must be reached during regular trading hours, not in pre-market or after-hours trading.

The market will resolve as NO if:

• The stock price never reaches 200 SEK during 2025

• The company is delisted before reaching 200 SEK

• Trading is suspended for the entire year

Considerations

• This would represent a >240% increase from the initial listing price of 58 SEK

• Stock splits or reverse splits will be adjusted for accordingly (e.g., if there's a 2:1 split, the target price would become 100 SEK)

• In case of a merger, acquisition, or other corporate action that affects the stock price, resolution will be based on the equivalent value of the original shares